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ABSTRACT
Background: Patients receiving maintenance hemodialysis (HD) are at higher risk for hepatitis B virus (HBV) 
infections than in general population. Strict infection control is essential to prevent nosocomial transmission. 
We aimed to investigate the incidence of HBV infection in the HD population in Sanglah General Hospital as 
well as risk factors acquired HBV infection.
Method: All adult patients receiving maintenance HD (n=267) in 3 dialysis units at Sanglah Hospital were 
studied between March to June 2016. In this study, medical record of patients on maintenance hemodialysis were 
reviewed and the patients were interviewed by the researchers to collect data regarding the serology status of 
these patients before and during HD, and potential risk factors which could be associated with HBV acquisition.
Results: Participant mean age was 54.07 ± 0.80 years and 154 (57.7%) were male. We found 21 patients (7.8%) 
were sero-positive for HBV (HBsAg positive) with mean titer was 9.26 ± 1.85. Of the sero-positive patients,1 
patient (4.8%) were known to be infected before the initiation of HD and 20 patients (95.2%) were infected 
during HD. Incidence of HBV infection during HD was 7.5% (20/266). Sero-positive patients were younger with 
mean age was 51.81 ± 2.76 years, had longer time on dialysis and had previous blood transfusions. Risk factors, 
which signi?cant associated with hepatitis B infection were history of transfusion (p ? 0.01? OR = 2.49? 95% 
?I: 1.29-8.18) and duration of hemodialysis (p ? 0.01? OR = 1.07? 95% ?I: 1.03-3.74).
Conclusion: Patients on maintenance HD in Sanglah General Hospital have a high incidence of HBV 
infection. The factors associated with HBV infection are highly suggestive of nosocomial transmission within 
HD units. History of transfusion and duration of hemodialysis were signi?cant risk factors for HBV infection in 
patients receiving maintenance HD.
Keywords: hemodialysis, hepatitis B, incidence, risk factor
ABSTRAK
Latar belakang: Pasien-pasien yang menerima perawatan hemodialisis (HD) berada pada risiko yang 
tinggi untuk terinfeksi virus hepatitis B dibandingkan populasi umum. Kontrol terhadap kejadian infeksi sangat 
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penting untuk mencegah penularan nosokomial. Penilitian ini bertujuan untuk menyelidiki kejadian infeksi 
virus hepatitis B pada populasi HD di Rumah Sakit Umum Sanglah serta faktor risiko penularan infeksi virus 
hepatitis B pada populasi HD.
Metode: Semua pasien dewasa yang menerima perawatan HD rutin (n = 267) di 3 unit dialisis di Rumah 
Sakit Sanglah dipelajari antara Maret-Juni 2016. Dalam penelitian ini, rekam medis pasien pada perawatan 
hemodialisis ditinjau dan pasien diwawancarai oleh peneliti untuk mengumpulkan data mengenai status serologi 
pasien sebelum dan selama HD, dan faktor-faktor risiko potensial yang dapat dikaitkan dengan penularan virus 
hepatitis B.
Hasil: Usia rata-rata pasien adalah 54,07 ± 0,80 tahun dengan 154 (57,7%) orang laki-laki. Kami memperoleh 
21 pasien (7,8%) yang sero-positif untuk virus hepatitis B (HBsAg positif) dengan titer rata-rata adalah 9,26 
± 1,85. Dari pasien yang sero-positif, 1 pasien (4.8%) diketahui terinfeksi sebelum memulai HD dan 20 pasien 
(95,2%) terinfeksi pada saat HD. Angka kejadian infeksi virus hepatitis B selama HD adalah 7,5% (20/266). 
pasien sero-positif yang lebih muda dengan rata-rata usia adalah 51,81 ± 2,76 tahun, memiliki durasi yang 
lebih lama untuk hemodialisis dan memiliki riwayat transfusi darah sebelumnya. ?aktor risiko yang signi?kan 
yang terkait dengan infeksi virus hepatitis B adalah riwayat transfusi (p ? 0,01? OR = 2,49? 95% ?I: 1,29-8,18) 
dan durasi hemodialisis (p ? 0,01? OR = 1,07? 95% ?I: 1,03-3,74).
Simpulan: Pasien yang menjalani HD rutin di Rumah Sakit Umum Sanglah memiliki insiden tinggi infeksi 
virus hepatitis B. Faktor yang terkait dengan infeksi virus hepatitis B sangat dicurigai melalui penularan 
nosokomial dalam unit HD. Sejarah transfusi dan durasi hemodialisis merupakan faktor risiko yang signi?kan 
untuk infeksi virus hepatitis B pada pasien yang menerima perawatan HD.
Kata kunci: hemodialisis, hepatitis B, angka kejadian, faktor risiko
INTRODUCTION
Chronic hemodialysis patients are at high risk 
for infection because the process of hemodialysis 
requires vascular access for prolonged periods. Patients 
receiving maintenance haemodialysis (HD) therapy 
are at increased risk for acquiring these infections 
and have a higher prevalence of hepatitis B virus 
(HBV) infection than in general population.1,2 In an 
environment where multiple patients receive dialysis 
concurrently, repeated opportunities e?ist for person?
to-person transmission of infectious agents, directly 
or indirectly via contaminated devices, equipment 
and supplies, environmental surfaces, or hands of 
personnel. Furthermore, hemodialysis patients are 
immunosuppressed.2
Prior to effective screening of blood donations, HBV 
infection was associated with blood transfusions needed 
to correct the anaemia associated with kidney disease 
but patient to patient transmission in HD units is also 
reported.3,4,5,6 HBV infection is usually due to patient 
to patient transmission within HD units.7 Recognition 
of the risk of nosocomial infection has resulted in 
recommendations that strict infection control procedures 
should be in HD units; patients with blood-borne virus 
infections should be isolated from sero-negative patients 
during dialysis and patients as well as staff should 
be vaccinated against hepatitis B.8,9 The introduction 
of blood donor screening and a reduction in blood 
transfusions due to the availability of recombinant 
erythropoietin has signi?cantly reduced the incidence 
of new HBV infections among HD patients in many 
countries.10,11,12 The prevalence of HBV infection in HD 
patients in Indonesia is still unclear. Several studies have 
been conducted in West Java found 6.8% HD patients 
had HbsAg seropositive.13 While research in Yogyakarta 
found 11.2% HD patients had HbsAg seropositive.14 
some HD centre are not reported the prevalence of HBV 
infection in their centre. 
Indonesia provides free access to maintenance 
HD for end stage kidney disease through a rapidly 
e?panding network of centres. The national dialysis 
practice guidelines or infection control polices 
enforced by health care authorities is general agreement 
that patients on HD should be screened for HBV 
and  hepatitis C virus (HCV) infection before the 
initiation of HD and monitored every 3–6 months 
there after.15 Sero-positive patients are dialysed on 
dedicated machines either in an isolated area or 
alongside sero-negative patients if space does not 
allow isolation.16 Although the prevalence of HBV in 
patients with end stage renal failure (ESRF) undergoing 
dialysis has decreased signi?cantly during the past 
few decades, it is still a distinct clinical problem, as 
the immunosuppressive nature of renal disease often 
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leads to chronicity of the viral infection and results in 
an opportunity for nosocomial spread of the infection 
among dialysis patients.1,17 Hepatitis B research on 
HD patients in Bali has not been reported, therefore, 
researchers are interested to know the incidence of 
HBV infection in HD patients in Bali. This study aimed 
to investigate for the ?rst time the incidence of HBV 
infection in the entire HD population of Denpasar.
METHOD
This descriptive study was carried out in 3 dialysis 
units at Sanglah General Hospital to investigate 
the incidence of HBV infection in HD patients (n = 
267) from March 2016 to June 2016. The data was 
collected regarding all adult patients in maintenance 
HD facilities. Large and medium capacity HD facilities 
were visited by the researchers in order to collect data. 
Patient medical records were used to obtain patients 
age, gender, time on HD, medical history, sero-
positivity to HBV as well as other laboratory results. 
These included history of blood transfusions and 
history of surgery. Sero-positivity to HBV was de?ned 
by detection of hepatitis B surface antigen (HBsAg) 
by enzyme linked immunoassay (ELISA). ELISA tests 
were performed in local laboratories. Data of HBsAg 
patient in the beginning of HD were collected too, to 
know the base line status of HBV infection. 
Data are presented as mean ± SD if normally 
distributed or median (interquartile range) if not. 
Analysis was performed using SPSS version 16.0. 
A Chi-square test was used to compare frequencies 
between groups. A t-test was used to compare means 
between groups for data with normal distribution or 
Mann–Whitney test for non-parametric data.
RESULTS
Participant mean age was 54.07 ± 0.80 years with 
median age of adult HD patients included was 54 years 
(range 20–86 years) and 57.7% were male. A total of 
21 patients (7.8%) were sero-positive for HBV (HBsAg 
positive). Patients were grouped based on HBV infection 
status. Group patient with HBV infection was comprised 
of 21 (7.8%) patients who were HBsAg positive. Group 
without HBV infection consisted of 246 (92.2%) patients 
who were HBsAg negative. Sero-positive patients were 
younger with mean age was 51.81 ± 2.76 years, had 
longer time on dialysis (5.21 ± 1.20 years) and had 
previous blood transfusions. The baseline demographic 
and laboratory data characteristics of the patients are 
summarized in Table 1? 
In the beginning of HD, from the medical record, we 
know that 1 patient (4.8%) was to be infected before the 
initiation of HD and 20 patients (95.2%) were infected 
during HD. Incidence of HBV infection during HD 
was 7.5% (20/266). Analysis of possible risk factors 
for HBV infections is shown in Table 2. Only duration 
of dialysis (p < 0.01; OR: 1.07; 95% CI: 1.03-3.74) 
and history of previous transfusion (p < 0.01; OR: 
2.49; 95%CI: 1.29-8.18) were signi?cantly different 
between patients who sero-converted and those who 
remained sero-negative.
??????????????????????????????????????????????????????????????????????
Variable Total Patient (n = 267)n (%)
Patient with hepatitis B 
(n = 21) 
n (%)
Patient without hepatitis B 
(n = 246) 
n (%)
p value
Age (year) 54.07 ± 0.80* 51.81 ± 2.76* 54.01 ± 13.2* 0.3
Gender
Male
Female 
154 (57.7)
113 (42.3)
13 (61.9)
8 (38.1) 
141 (58.5)
105 (41.4) 
0.4
Age category (year old)
< 60 
? 60 
183 (68.5) 
84 (31.5)
17 (80.9)
4 (19.1) 
166 (67.4)
80 (32.6) 
0.19
Duration of HD (year) 4.87 ± 0.80* 5.21±1.20* 4.56 ± 7.21* 0.03
Duration of HD (years)
? 2 
> 2 
100 (37.5)
167 (62.5)
3 (14.2)
18 (85.8) 
97 (39.4)
149 (60.6) 
< 0.01
History of transfusion
Yes
No 
156 (58.4)
111 (41.6)
20 (95.2)
1 (4.8) 
136 (55.2)
110 (44.8) 
< 0.01
History of Surgery
Yes
No 
249 (93.2)
18 (6.8)
20 (95.2)
1 (4.8) 
229 (93.1)
17 (6.9) 
0.4
ALT (U/L) 22.15 ± 1.50* 30.12 ± 2.38* 17.81 ± 0.76* 0.09
AST (U/L) 21.95 ± 1.08* 24.52 ± 6.83* 19.77 ± 5.51* 0.1
Albumin (g/dL) 4.10 ± 0.39* 3.99 ± 0.38* 4.16 ± 0.39* 0.4
*SD, mean; HD: hemodialysis; ALT: alanine aminotransferase; AST: aspartate aminotransferase
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DISCUSSION
Patients on maintenance HD are among the 
group at highest risk for HBV infection. Most HBV 
infection outbreaks in patients in HD units are caused 
by cross-contamination via the following factors: (1) 
Environmental surfaces, supplies (e.g., hemostats and 
clamps), or equipment that is not routinely disinfected 
after each use; (2) Multiple dose medication vials and 
intravenous solutions that are not used e?clusively 
for one patient; (3) Medications for injection that 
are prepared in areas adjacent to areas where blood 
samples are handled; and (4) Staff members who 
simultaneously care for both HBV-infected and 
susceptible patients. The risk of HBV transmission 
from blood contaminated items in this setting is greater 
and more serious than would be e?pected for other 
common blood borne viruses.1,2,4
In general the observed incidence of HBV infection 
(7.5%) is higher to the general population and higher 
than reported in HD patients in other regions including 
Europe (4.1%), Japan (2.2%) and the USA (2.4%).18 A 
study sample from the dialysis outcome and practice 
patterns study that included 8615 adult HD patients 
from 308 dialysis facilities in Western Europe and 
the United States, reported incidence rates for HBV 
infection ranging from 0-6.6%.19 Studies from less 
developed countries estimated that the proportion of 
HBsAg carriers in the HD population varies from 2% 
to 20%.20-23 A recent multicenter prospective cohort 
study among dialysis patients in Korea revealed that 
7.1% were HBsAg-positive.21 In Vietnam, 7% of HD 
patients tested positive for HBsAg.22 Several studies 
have also been performed in Indonesia, studies were 
conduct in West Java and Yogyakarta, they report that 
the prevalence of HBV infection in HD patient were 
6.8% and 11.2%.13,14 
Some countries have different policies regarding 
blood transfusions and the use of special machines 
HD in patients with HBV infection are becoming some 
factors that in?uence in the transmission of HBV. In 
some developed countries, precautions HBV infection 
during blood donation and when initation of HD might 
have been better than the developing countries. Giving 
the vaccine has also been routinely performed on 
patients undergoing HD regular. While in Indonesia, 
especially in Bali, is not routinely performed.15-17
The prevalence and incidence of HBV infections in 
HD patients re?ects the prevalence of these infections 
in the general population, the quality of healthcare 
services in a community and the standards of infection 
control practices in HD units. The importance of HBV 
as a health risk in patients on HD is illustrated by 
observation that 3% of deaths in Libyan HD patients 
during a 1 year observation period were due to liver 
failure and that 13 of the 14 patients who died of liver 
failure were sero-positive for HBV.24
Our data show that sero-positive patients were 
younger on average than sero-negative patients. This 
observation is in agreement with a previous report 
from Libya showing that the highest prevalence of 
HBV infection was observed in HD patients aged 
36–55 years.25,26 Other studies have reported a higher 
prevalence of HBV sero-positivity in older patients 
and the reason for this difference in not clear.16 On 
the other hand, the prevalence and incidence of 
HBV sero-positivity was significantly related to 
the length of time on HD. This is consistent with 
nosocomial transmission related to dialysis since 
longer duration of dialysis represents a longer period 
at risk of acquiring an infection. Similar observations 
have been reported by other authors.27,28 Prevention 
of nosocomial transmission is importance in HBV 
infection transmission. 
Table 2. Analisis of risk factors of hepatitis B infection on HD population
Variable Patient with hepatitis B (n = 20) 
n (%)
Patient without 
hepatitis B (n = 246) 
n (%)
OR 95% CI p value
Age category 
(year old)
< 60 
? 60 
16 (80)
4 (20) 
166 (67.4)
80 (32.6) 
 
2.06 0.67-6.32 0.19
Duration of HD (years)
? 2
> 2 
2 (10)
18 (90) 
97 (39.4)
149 (60.6) 
1.07 1.03-3.74 < 0.01*
History of transfusion
Yes 
No 
19 (95)
1 (5) 
136 (55.2)
110 (44.8) 
2.49 1.29-8.18 < 0.01*
History of surgery
Yes 
No 
19 (95)
1 (5) 
229 (93.1)
17 (6.9) 
1.49  0.18-11.79 0.703
*p < 0,05; HD: hemodialysis
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A positive history of blood transfusions was 
strongly associated with HBV infection. Prior to the 
introduction of effective screening of blood donors, 
blood transfusions were recognized as the leading 
source of HBV infection and some of these infections 
may have been acquired before adequate screening 
was introduced.29,30 In addition it is possible that some 
blood donors with HBV infection are being missed 
by current screening procedures and these may need 
to be reassessed.31,32 A large proportion of patients 
had previously received blood transfusions. The 
risk of infection could therefore be further reduced 
by more effective management of anemia with iron 
supplementation and erythropoietin.33 
Another concern raised by the current study is 
that HBV infection was associated with duration 
of HD. The positive association between HBV 
prevalence and years on hemodialysis has been found 
previously. Albertoni et al reported a sharp increase 
in HbsAg carriers in patients with 10 years or more 
of hemodialysis, a ?nding they attributed to a cohort 
effect.34 In our study demonstrate a markedly higher 
HBV prevalence in patients with 3 years or more of 
hemodialysis (Figure 1). The positive association 
between HBV prevalence and years of hemodialysis 
has several possible e?planations. Although less 
likely, it is possible that patients who have undergone 
hemodialysis for a longer period of time have a longer 
time at risk for e?posure to HBV than those patients 
who have been on hemodialysis for a shorter amount 
of time.
Figure 1. Variation in hepatitis B virus (HBV) prevalence by 
patient’s time on dialysis
In general hospitals in Indonesia, dialyzers are 
commonly reused up to a ma?imum of eight times for 
all patients. Following the recommendations for HBV 
and HCV infection control issued by the Indonesian 
Society of Nephrology, separate rooms are available 
for patients who are HBsAg seropositive. Based on the 
slightly higher prevalence of HBV infection among 
HD patients than the general population (2.5-10%) 
in Indonesia, there is a strong possibility that the 
prevalence of HBV infections among HD patients is 
caused by nosocomial infections.23,24 Our study also 
showed that the HD duration and number of blood 
transfusions were signi?cantly associated with HBV 
infection. 
A striking observation from this study is the 
wide variation in incidence and prevalence of HBV 
infections among different HD units. Most facilities 
faced a problem of increasing number of patients 
and most of them responded by adding more HD 
stations at e?pense of space and staff. Infection control 
precautions also varied widely between centres. They 
were strictly enforced in some places but frequently 
breached in others. This seemed to depend on staff 
initiative rather than national guidelines. On the 
other hand, dialyser reuse was not permitted and all 
bloodlines as well as other consumables were disposed 
after a single use.13 Some brands of HD machines were 
equipped with a sphygmomanometer. Otherwise, most 
non- disposable instruments used in HD environment 
were shared between sero-positive and sero-negative 
patients. The use of multi-dose vials of heparin was 
common and is likely to have been an important 
cause of nosocomial infections. Many patients started 
HD without being vaccinated against HBV. Even in 
vaccinated patients the antibody titre was not assessed. 
The wide variation in HBV prevalence and incidence 
between dialysis centres implies that there is potential 
to reduce blood-borne virus infection by transferring 
best practice from HD centers with low infection rates. 
In particular infection control procedures should be 
investigated in centers with high infection rates and 
the use of multidose heparin vials must be stopped 
urgently. Previous studies from the region show that 
with appropriate intervention HBV infection rates 
in HD centers may be substantially improved. For 
e?ample in Iran, HBV prevalence reduced from 14.4% 
in 1999 to 4.5% in 2006 and in Saudi Arabia from 2.4% 
in 2001 to 0.2% in 2005.35,36
Several limitations of this study should be conceded. 
Medical records were often incomplete and additional 
clinical information was frequently obtained by 
interviewing staff and patients. Data regarding hepatitis 
B core antibodies (HBcAb) or hepatitis B DNA were 
not available. In one recent study of haemodialysis 
patients in Egypt who were negative for HBsAg, 
hepatitis B DNA was detected in 4.1% and HBcAb in 
20%.37 It is therefore possible that we failed to detect 
cases of occult hepatitis B infection. 
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CONCLUSION
In conclusion, patients on maintenance HD in 
Sanglah Hospital Denpasar have high incidence 
rates of HBV infection. The factors associated with 
HBV infection are highly suggestive of nosocomial 
transmission within HD units. In our study, history 
of transfusion and duration of hemodialysis were 
signi?cant risk factors for HBV infection in patients 
receiving maintenance HD. Urgent action is required 
to improve infection control measures in HD centers 
and to reduce dependence on blood transfusions for 
the treatment of anemia. 
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